Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS - PubMed (original) (raw)
Multicenter Study
doi: 10.1038/ng934. Epub 2002 Jul 22.
Xiaojiang Gao, Jeong-Hee Lee, George W Nelson, Roger Detels, James J Goedert, Susan Buchbinder, Keith Hoots, David Vlahov, John Trowsdale, Michael Wilson, Stephen J O'Brien, Mary Carrington
Affiliations
- PMID: 12134147
- DOI: 10.1038/ng934
Multicenter Study
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS
Maureen P Martin et al. Nat Genet. 2002 Aug.
Abstract
Natural killer (NK) cells provide defense in the early stages of the innate immune response against viral infections by producing cytokines and causing cytotoxicity. The killer immunoglobulin-like receptors (KIRs) on NK cells regulate the inhibition and activation of NK-cell responses through recognition of human leukocyte antigen (HLA) class I molecules on target cells KIR and HLA loci are both highly polymorphic, and some HLA class I products bind and trigger cell-surface receptors specified by KIR genes. Here we report that the activating KIR allele KIR3DS1, in combination with HLA-B alleles that encode molecules with isoleucine at position 80 (HLA-B Bw4-80Ile), is associated with delayed progression to AIDS in individuals infected with human immunodeficiency virus type 1 (HIV-1). In the absence of KIR3DS1, the HLA-B Bw4-80Ile allele was not associated with any of the AIDS outcomes measured. By contrast, in the absence of HLA-B Bw4-80Ile alleles, KIR3DS1 was significantly associated with more rapid progression to AIDS. These observations are strongly suggestive of a model involving an epistatic interaction between the two loci. The strongest synergistic effect of these loci was on progression to depletion of CD4(+) T cells, which suggests that a protective response of NK cells involving KIR3DS1 and its HLA class I ligands begins soon after HIV-1 infection.
Similar articles
- KIR/HLA pleiotropism: protection against both HIV and opportunistic infections.
Qi Y, Martin MP, Gao X, Jacobson L, Goedert JJ, Buchbinder S, Kirk GD, O'Brien SJ, Trowsdale J, Carrington M. Qi Y, et al. PLoS Pathog. 2006 Aug;2(8):e79. doi: 10.1371/journal.ppat.0020079. PLoS Pathog. 2006. PMID: 16933987 Free PMC article. - KIR3DS1/L1 and HLA-Bw4-80I are associated with HIV disease progression among HIV typical progressors and long-term nonprogressors.
Jiang Y, Chen O, Cui C, Zhao B, Han X, Zhang Z, Liu J, Xu J, Hu Q, Liao C, Shang H. Jiang Y, et al. BMC Infect Dis. 2013 Sep 2;13:405. doi: 10.1186/1471-2334-13-405. BMC Infect Dis. 2013. PMID: 24059286 Free PMC article. - Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations.
Lopez-Larrea C, Blanco-Gelaz MA, Torre-Alonso JC, Bruges Armas J, Suarez-Alvarez B, Pruneda L, Couto AR, Gonzalez S, Lopez-Vázquez A, Martinez-Borra J. Lopez-Larrea C, et al. Arthritis Res Ther. 2006;8(4):R101. doi: 10.1186/ar1988. Arthritis Res Ther. 2006. PMID: 16805919 Free PMC article. - Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses.
Gaudieri S, Nolan D, McKinnon E, Witt CS, Mallal S, Christiansen FT. Gaudieri S, et al. Mol Immunol. 2005 Feb;42(4):557-60. doi: 10.1016/j.molimm.2004.07.041. Mol Immunol. 2005. PMID: 15607813 Review. - The role genes encoding of killer cell immunoglobulin-like receptors (KIRs) and their ligands in susceptibility to and progression of HIV infection.
Błachowicz O, Zwolińska K. Błachowicz O, et al. Postepy Hig Med Dosw (Online). 2016 Dec 31;70(0):1409-1423. doi: 10.5604/17322693.1227771. Postepy Hig Med Dosw (Online). 2016. PMID: 28100849 Review.
Cited by
- The Role of Natural Killer Cells and Their Metabolism in HIV-1 Infection.
Naidoo KK, Altfeld M. Naidoo KK, et al. Viruses. 2024 Oct 9;16(10):1584. doi: 10.3390/v16101584. Viruses. 2024. PMID: 39459918 Free PMC article. Review. - Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells.
Sáez-Cirión A, Mamez AC, Avettand-Fenoel V, Nabergoj M, Passaes C, Thoueille P, Decosterd L, Hentzien M, Perdomo-Celis F, Salgado M, Nijhuis M, Mélard A, Gardiennet E, Lorin V, Monceaux V, Chapel A, Gourvès M, Lechartier M, Mouquet H, Wensing A, Martinez-Picado J, Yerly S, Rougemont M, Calmy A. Sáez-Cirión A, et al. Nat Med. 2024 Dec;30(12):3544-3554. doi: 10.1038/s41591-024-03277-z. Epub 2024 Sep 2. Nat Med. 2024. PMID: 39222660 Free PMC article. - Impact of Human Leukocyte Antigen Allele-Killer Cell Immunoglobulin-like Receptor Partners on Sexually Transmitted Human Immunodeficiency Virus Type 1 Infection.
Serrano-Rísquez C, Omar M, Rallón N, Benito JM, Gómez-Vidal A, Márquez FJ, Alján M, Rivero-Juárez A, Pérez-Valero I, Rivero A, Sinangil F, Saulle I, Biasin M, Clerici M, Forthal D, Saéz ME, Caruz A. Serrano-Rísquez C, et al. J Infect Dis. 2024 Nov 15;230(5):e1077-e1081. doi: 10.1093/infdis/jiae436. J Infect Dis. 2024. PMID: 39208444 Free PMC article. - Polymorphic residues in HLA-B that mediate HIV control distinctly modulate peptide interactions with both TCR and KIR molecules.
Tano-Menka R, Singh NK, Muzhingi I, Li X, Mandanas MV, Kaseke C, Crain CR, Zhang A, Ogunshola FJ, Vecchiarello L, Piechocka-Trocha A, Bashirova A, Birnbaum ME, Carrington M, Walker BD, Gaiha GD. Tano-Menka R, et al. Structure. 2024 Aug 8;32(8):1121-1136.e5. doi: 10.1016/j.str.2024.04.015. Epub 2024 May 10. Structure. 2024. PMID: 38733995 Free PMC article. - Tissue-specific features of innate lymphoid cells in antiviral defense.
Piersma SJ. Piersma SJ. Cell Mol Immunol. 2024 Sep;21(9):1036-1050. doi: 10.1038/s41423-024-01161-x. Epub 2024 Apr 29. Cell Mol Immunol. 2024. PMID: 38684766 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials